You searched for "tumour"
Fluorescein use during parotidectomy
The authors of this study retrospectively reviewed the surgical charts of seven patients who underwent parotidectomy for tumour resection. In all these patients, Fluorescein sodium was used to enhance the contrast between parotid tumour tissue and the facial nerve. Using...
Depth of invasion of oral cancer should be incorporated in new AJCC staging system
Since 1977, when the first edition of the Manual for Staging of Cancer was published by the American Joint Committee on Cancer (AJCC), the primary tumour staging for oral squamous cell carcinoma (SCC) has remained unchanged. In the last four...
Is there a limitation for excising parapharyngeal tumours transorally?
The parapharyngeal space is a complex anatomical space bounded medially by the oropharynx and laterally by the mandible. It is conceptualised as an inverted pyramid extending from base of skull above to the hyoid bone below. The space is divided...
New biomarkers for salivary gland tumours
Salivary gland tumours comprise approximately 6-8% of head and neck neoplasms. Elevated haematological inflammatory markers, such as neutrophil to lymphocyte ratio (NLR) and platelet to lymphocyte ratio (PLR), have been shown to be predictive and prognostic in various malignancies. This...Current management of unilateral sporadic vestibular schwannoma
Vestibular schwannoma is the commonest tumour of the cerebellopontine angle (80%) and accounts for around 8% of all intracranial tumours. The commonest primary presenting symptoms are audio vestibular. Hearing health professionals are often the first contact for patients with potential symptoms of vestibular schwannoma, with the majority then being seen and diagnosed by otorhinolaryngologists.
Cochlear implantation in inner ear schwannoma patients
Inner ear schwannomas (IES) are rare. Patients with IES tend to lose their hearing. Surgery is a treatment option, but it leads to complete loss of hearing. Other treatment options include stereotactic radiosurgery (SRS) and watchful waiting (WW). The authors...
Outcomes of larger glottic cancer volumes treated with radiotherapy
T3 glottic cancer is characterised as vocal cord fixation and/or invasion into pre-epiglottic, post-cricoid, paraglottic spaces and/or within the inner cortex of thyroid cartilage. Traditionally, laryngectomy was considered the primary option to treat T3 laryngeal glottic cancers until other options...In conversation with Professor Valerie J Lund CBE
Valerie Lund is Professor of Rhinology at the Ear Institute, University College London and is an Honorary Consultant ENT Surgeon at the Royal National Throat Nose and Ear Hospital (Royal Free Trust), Moorfields Eye Hospital, University College Hospital and Imperial...
Radiosurgery for large vestibular schwannomas
The authors conducted a retrospective study of patients with large Koos grade 4 vestibular schwannomas undergoing gamma knife radiosurgery. A total of 68 patients with tumour size greater than 4 cm3 with baseline serviceable 60% hearing who received 12 Gray...
Facial nerve grafting – what’s the wait?
An uninterrupted facial nerve after resection of cerebellopontine angle (CPA) tumour does not always translate into preserved facial animation. Fortunately there is a high probability spontaneous recovery may occur and hence patients are typically observed for 12 months postoperatively. However,...Harnessing head and neck cancer genomics for personalised medicine
Luc Morris updates us on the future of cancer diagnosis and treatment, which lies in “personalised oncology”, where specific molecular alterations of each tumour will be identified, and matched with actionable alterations in existing therapies, ushering in the era of...
